Literature DB >> 20237891

AFOMP POLICY STATEMENT No. 2: recommended clinical radiation oncology medical physicist staffing levels in AFOMP countries.

W H Round1, Y K Tay, K H Ng, K Y Cheung, S Fukuda, Y Han, Y X Huang, H J Kim, A Krisanachinda, H L Liu.   

Abstract

This document is the second of a series of policy statements being issued by the Asia-Oceania Federation of Organizations for Medical Physics (AFOMP). The document was developed by the AFOMP Professional Development Committee (PDC) and was released by the AFOMP Council in 2009. The main purpose of the document is to give guidance as to how many medical physicists are required to staff a radiation oncology department. Strict guidelines are difficult to define as work practices vary from country-to-country and from hospital-to-hospital. A calculation scheme is presented to aid in estimating medical physics staffing requirements that is primarily based on equipment levels and patient numbers but also with allowances for staff training, professional development and leave requirements.

Entities:  

Mesh:

Year:  2010        PMID: 20237891     DOI: 10.1007/s13246-010-0003-y

Source DB:  PubMed          Journal:  Australas Phys Eng Sci Med        ISSN: 0158-9938            Impact factor:   1.430


  3 in total

1.  Should ACPSEM develop its own position papers or just adopt those of the AAPM?

Authors:  Tomas Kron; Peter Metcalfe; Clive Baldock
Journal:  Phys Eng Sci Med       Date:  2020-09

2.  Medical physics aspects of cancer care in the Asia Pacific region: 2011 survey results.

Authors:  T Kron; Ha Azhari; Eo Voon; Ky Cheung; P Ravindran; D Soejoko; K Inamura; Y Han; Nm Ung; L Bold; Um Win; R Srivastava; J Meyer; S Farrukh; L Rodriguez; M Kuo; Jcl Lee; A Kumara; Cc Lee; A Krisanachinda; Xc Nguyen; Kh Ng
Journal:  Biomed Imaging Interv J       Date:  2012-04-01

3.  Medical physics staffing for radiation oncology: a decade of experience in Ontario, Canada.

Authors:  Jerry J Battista; Brenda G Clark; Michael S Patterson; Luc Beaulieu; Michael B Sharpe; L John Schreiner; Miller S MacPherson; Jacob Van Dyk
Journal:  J Appl Clin Med Phys       Date:  2012-01-05       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.